+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viracept"

Global HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Viracept is an antiviral drug used to treat HIV infection. It is a protease inhibitor, meaning it blocks the action of the HIV protease enzyme, which is necessary for the virus to replicate. Viracept is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who have been exposed to the virus. The market for Viracept is part of the larger market for infectious diseases drugs. This market includes drugs used to treat a wide range of infectious diseases, including HIV, hepatitis, tuberculosis, and malaria. The market is highly competitive, with many companies offering similar products. Some of the companies in the Viracept market include AbbVie, Gilead Sciences, Merck, and Pfizer. Show Less Read more